Effects of peroxynitrite on isolated cardiac trabeculae: Selective impact on myofibrillar energetic controllers

Biochimie

Volumn 85, Issue 6, 2003, Pages 587-596

  Mihm, Michael J ^a,b   Yu, Fushun ^b   Reiser, Peter J ^b   Bauer, John Anthony ^a,b,c  

^a THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Creatine kinase; Energetics; Peroxynitrite; Proteomics

Indexed keywords

ACTIN; ADENOSINE TRIPHOSPHATE; ALPHA ACTININ; CELL PROTEIN; CREATINE KINASE ISOENZYME; CREATINE KINASE MM; CREATINE PHOSPHATE; DESMIN; MYOSIN HEAVY CHAIN; MYOSIN LIGHT CHAIN; PEROXYNITRITE; PHOSPHATE; TROPOMYOSIN; TROPONIN; TYROSINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ENERGY; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; DRUG EXPOSURE; DRUG HALF LIFE; DRUG SENSITIVITY; ENZYME INACTIVATION; ENZYME SUBSTRATE; HEART FUNCTION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART VENTRICLE WALL; ISOLATED HEART; MALE; MUSCLE FIBRIL; NITRATION; NONHUMAN; PROTEIN CONTENT; RAT;

EID: 0038422171     PISSN: 03009084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9084(03)00090-7     Document Type: Article

References (47)

1. A.M. Shah, P.A. MacCarthy, Paracrine and autocrine effects of nitric oxide on myocardial function, Pharmacol. Ther. 86 (2000) 49-86.
2. N.G. Vejlstrup, A. Bouloumie, S. Boesgaard, C.B. Andersen, J.E. Nielsen-Kudsk, S.A. Mortensen, J.D. Kent, D.G. Harrison, R. Busse, J. Aldershvile, Inducible nitric oxide synthase (iNOS) in the human heart: Expression and localization in congestive heart failure, J. Mol. Cell. Cardiol. 30 (1998) 1215-1223.
3. G.A. Haywood, P.S. Tsao, H.E. Von Der Leyen, M.J. Mann, P.J. Keeling, P.T. Trindale, N.P. Lewis, C.D. Byrne, P.R. Rickenbacher, N.H. Bishopric, J.P. Cooke, W.J. McKenna, M.B. Fowler, Expression of inducible nitric oxide synthase in human heart failure, Circulation 93 (1996) 1087-1094.
4. R.S. Ronson, M. Nakamura, J. Vinten-Johansen, The cardiovascular effects and implications of peroxynitrite, J. Cardiovasc. Res. 44 (1999) 47-59.
5. R. Radi, J. Beckman, K. Bush, B. Freeman, Peroxynitrite-induced membrane lipid peroxidation: The cytotoxic potential of superoxide and peroxynitrite, Arch. Biochem. Biophys. 288 (1996) 481-487.
6. J.S. Beckman, W. Koppenol, Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and the ugly, Am. J. Physiol. 271 (1996) C1424-C1437.
7. R. Meli, T. Nauser, P. Latal, W.H. Koppenol, Reaction of peroxynitrite with carbondioxide: Intermediates and determination of the yield of CO3*- and NO2*, J. Biol. Inorg. Chem. 7 (2002) 31-36.
8. R. Radi, G. Peluffo, M.N. Alvarez, M. Naviliat, A. Cayota, Unraveling peroxynitrite formation in biological systems, Free Radic. Biol. Med. 30 (2001) 463-488.
9. C.D. Reiter, R.J. Teng, J.S. Beckman, Superoxide reacts with nitric oxide to nitrate tyrosine at physiological pH via peroxynitrite, J. Biol. Chem. 275 (2000) 32460-32466.
10. M.J. Mihm, C. Coyle, B.L. Schanbacher, D.W. Weinstein, J.A. Bauer, Peroxynitrite induced nitration and inactivation of myofibrillar creatine kinase in experimental heart failure, Cardiovasc. Res. 49 (2001) 798-807.
11. M.J. Mihm, C.Y. Liu, F. Yu, C.A. Carnes, P.J. Reiser, D.R. Van Wagoner, J.A. Bauer, Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation, Circulation 104 (2001) 174-180.
12. M.J. Mihm, F. Yu, P.J. Reiser, J.A. Bauer, Intracellular distribution of peroxynitrite formation in doxorubicin cardiotoxicity: Evidence of selective actions on myofibrillar creatine kinase, Br. J. Pharmacol. 135 (2002) 581-588.
13. D.M. Weinstein, M.J. Mihm, J.A. Bauer, Cardiac peroxynitrite formation and left ventricular dysfunction following doxorubicin treatment in mice, J. Pharmacol. Exp. Ther. 294 (2000) 396-401.
14. P. Ferdinandy, H. Danial, I. Ambrus, R.A. Rothery, R. Schulz, Peroxynitrite is a major contributor to cytokine-induced myocardial contractile failure, Circ. Res. 87 (2000) 241-247.
15. N.W. Kooy, S.J. Lewis, J.A. Royall, Y.Z. Ye, D.R. Kelly, J.S. Beckman, Extensive tyrosine nitration in human myocardial inflammation: Evidence for the presence of peroxynitrite, Crit. Care Med. 25 (1997) 812-819.
16. J. Wattanapermpool, P.J. Reiser, Differential effects of ovariectomy on calcium activation of cardiac and soleus myofilaments, Am. J. Physiol. 277 (1999) H467-H473.
17. L.D. Yates, M.L. Greaser, Quantitative determination of myosin and actin in rabbit skeletal muscle, J. Mol. Biol. 168 (1983) 123-141.
18. M. Sokolovsky, J.F. Riordan, B.L. Vallee, Tetranitromethane. A reagent for the nitration of tyrosyl residues in proteins, Biochemistry 5 (1966) 3582-3589.
19. H. Ischiropoulos, Biological tyrosine nitration: A pathophysiological function of nitric oxide and reactive oxygen species, Arch. Biochem. Biophys. 356 (1998) 1-11.
20. M.J. Mihm, J.A. Bauer, Peroxynitrite-induced inhibition and nitration of cardiac myofibrillar creatine kinase, Biochimie 84 (2002) 1013-1019.
21. H. Ishida, C. Genka, Y. Hirota, Y. Hamasaki, H. Nakazawa, Distinct roles of peroxynitrite and hydroxyl radical in triggering stunned myocardium-like impairment of cardiac myocytes in vitro, Mol. Cell. Biochem. 198 (1999) 31-38.
22. P. Ferdinandy, D. Panas, R. Schulz, Peroxynitrite contributes to spontaneous loss of cardiac efficiency in isolated working rat hearts, Am. J. Phys. 276 (1999) H1861-H1867.
23. Y.W. Xie, P.M. Kaminski, M.S. Wolin, Inhibition of rat cardiac muscle contraction and mitochondrial respiration by endogenous peroxynitrite formation during posthypoxic reoxygenation, Circ. Res. 82 (1998) 891-897.
24. R. Schulz, K.L. Dodge, G.D. Lopaschuk, A.S. Clanachan, Peroxynitrite impairs cardiac contractile function by decreasing cardiac efficacy, Am. J. Phys. 272 (1997) H1212-H1219.
25. W. Wang, G. Sawicki, R. Schulz, Peroxynitrite-induced myocardial injury is mediated through matrix metalloproteinase-2, Cardiovasc. Res. 53 (2002) 165-174.
26. I.L. Grupp, T.M. Jackson, P. Hake, G. Grupp, C. Szabo, Protection against hypoxia-reoxygenation in the absence of poly (ADP-ribose) synthetase in isolated working hearts, J. Mol. Cell. Cardiol. 31 (1999) 297-303.
27. P. Pacher, L. Liaudet, P. Bai, J.G. Mabley, P.M. Kaminski, L. Virag, A. Deb, E. Szabo, Z. Ungvari, M.S. Wolin, J.T. Groves, C. Szabo, Potent metalloporphyrin peroxynitrite decomposition catalyst protects against the development of doxorubicin-induced cardiac dysfunction, Circulation 107 (2003) 896-904.
28. R. Ventura-Clapier, V. Veksler, J. Hoerter, Myofibrillar creatine kinase and cardiac contraction, Mol. Cell. Biochem. 133/134 (1994) 125-144.
29. R. Ventura-Clapier, V.A. Saks, G. Vassort, C. Lauer, G.V. Elizarova, Reversible MM-creatine kinase binding to cardiac myofibrils, Am. J. Physiol. 253 (1987) C444-C455.
30. L. Nascimben, J.S. Ingwall, P. Pauletto, J. Friedrich, J.K. Gwathmey, V. Saks, A.C. Pessina, P.D. Allen, Creatine kinase system in failing and nonfailing human myocardium, Circulation 94 (1996) 1894-1901.
31. J.S. Ingwall, Is cardiac failure a consequence of decreased energy reserve? Circulation 87 (1993) VII58-VII62.
32. T. Wallimann, M. Dolder, U. Schlattner, M. Eder, T. Hornemann, E. O'Gorman, A. Ruck, D. Brdiczka, Some new aspects of creatine kinase (CK): Compartmentation, structure, function and regulation for cellular and mitochondrial bioenergetics and physiology, Biofactors 8 (1998) 229-234.
33. G.L. Squadrito, W.A. Pryor, Oxidative chemistry of nitric oxide: The roles of superoxide, peroxynitrite, and carbondioxide, Free Radic. Biol. Med. 25 (1998) 392-403.
34. H. Ishida, C. Genka, H. Nakazawa, Application of authentic peroxynitrite to biological materials, Meth. Enzymol. 301 (1999) 402-409.
35. T. Sawa, T. Akaike, H. Maeda, Tyrosine nitration by peroxynitrite formed from nitric oxide and superoxide generated by xanthine oxidase, J. Biol. Chem. 275 (2000) 32467-32474.
36. R.J. Teng, Y.Z. Ye, D.A. Parks, J.S. Beckman, Urate produced during hypoxia protects heart proteins from peroxynitrite-mediated protein nitration, Free Radic. Biol. Med. 33 (2002) 1243-1249.
37. W.H. Koppenol, 100 years of peroxynitrite chemistry and 11 years of peroxynitrite biochemistry, Redox Rep. 6 (2001) 339-341.
38. R. White, J. Crow, N. Spear, S. Thomas, R. Patel, I. Green, J. Beckman, V. Darley-Usmar, Making and working with peroxynitrite, Meth. Mol. Biol. 100 (1998) 215-230.
39. Y.M. Go, R.P. Patel, M.C. Maland, H. Park, J.S. Beckman, V.M. Darley-Usmar, H. Jo, Evidence for peroxynitrite as a signaling molecule in flow-dependent activation of c-Jun NH(2)-terminal kinase, Am. J. Physiol. 277 (1999) H1647-H1653.
40. R. Kissner, J.S. Beckman, W.H. Koppenol, Peroxynitrite studied by stopped-flow spectroscopy, Meth. Enzymol. 301 (1999) 342-352.
41. E.D. Crouser, M.W. Julian, D.M. Weinstein, R.J. Fahy, J.A. Bauer, Endotoxin-induced ileal mucosal injury and nitric oxide dysregulation are temporally dissociated, Am. J. Respir. Crit. Care Med. 161 (2000) 1705-1712.
42. M.J. Mihm, B.L. Schanbacher, L.J. Wallace, N.J. Uretsky, J.A. Bauer, Free 3-nitrotyrosine causes striatal neurodegeneration in vivo, J. Neurosci. 21 (2001) 11-15.
43. M.J. Mihm, S.K. Wattanapitayakul, S.-F. Piao, D.G. Hoyt, J.A. Bauer, Effect of angiotensin II on vascular endothelial cells: Receptor mediated reactive nitrogen species formation, Biochem. Pharmacol. 65 (2002) 1189-1197.
44. Y. Kamisaki, K. Wada, K. Bian, B. Balabanli, K. Davis, E. Martin, F. Behbod, Y.C. Lee, F. Murad, An activity in rat tissues that modifies nitrotyrosine-containing proteins, Proc. Natl. Acad. Sci. USA 95 (1998) 11584-11589.
45. W. Hemmer, E. Zanolla, E.M. Furter-Graves, H.M. Eppenberger, T. Wallimann, Creatine kinase isoenzymes in chicken cerebellum: Specific localization of brain-type creatine kinase in Bergmann glial cells and muscle-type creatine kinase in Purkinje neurons, Eur. J. Neurosci. 6 (1994) 538-549.
46. E. DeSousa, V. Veksler, A. Minajeva, A. Kaasik, P. Mateo, E. Mayoux, J. Hoerter, X. Bigard, B. Serrurier, R. Ventura-Clapier, Subcellular creatine kinase alterations: Implications in heart failure, Circ. Res. 85 (1999) 68-76.
47. S. Neubauer, M. Horn, M. Cramer, K. Harre, J.B. Newell, W. Peters, T. Pabst, G. Ertl, D. Hahn, J.S. Ingwall, K. Kochsiek, Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy, Circulation 96 (1997) 2190-2196.